The Companion Animal Wound Care market outlook remains highly attractive, driven by rising pet humanization trends, advancements in veterinary medicine, and growing demand for specialized therapeutics. Market growth is further supported by increasing prevalence of chronic conditions in pets and a surge in surgical procedures. However, competitive intensity is moderate, with established players dominating through proprietary technologies, while niche innovators target unmet needs in niche segments like chronic wound management. The long-term outlook is optimistic, with emerging economies offering untapped potential amid rising disposable incomes and awareness. The innovation landscape is dynamic, focusing on antimicrobial dressings, regenerative biomaterials, and telemedicine-enabled monitoring solutions. Demand–supply balance remains stable, though regional disparities in product accessibility and pricing pressures pose challenges. Key risk factors include stringent regulatory requirements, fluctuating raw material costs, and potential market saturation in mature regions. Strategic partnerships and R&D investment will be critical for sustaining growth.